Li et al., 2024 - Google Patents
Adaptive enzyme-responsive self-assembling multivalent apelin ligands for targeted myocardial infarction therapyLi et al., 2024
- Document ID
- 2333438125694746072
- Author
- Li J
- Song X
- Liao X
- Shi Y
- Chen H
- Xiao Q
- Liu F
- Zhan J
- Cai Y
- Publication year
- Publication venue
- Journal of Controlled Release
External Links
Snippet
Microvascular dysfunction following myocardial infarction exacerbates coronary flow obstruction and impairs the preservation of ventricular function. The apelinergic system, known for its pleiotropic effects on improving vascular function and repairing ischemic …
- 208000010125 myocardial infarction 0 title abstract description 13
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | Injectable and pH-responsive self-assembled peptide hydrogel for promoted tumor cell uptake and enhanced cancer chemotherapy | |
| Zhao et al. | CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery | |
| Zhao et al. | Assembly of bifunctional aptamer–fibrinogen macromer for VEGF delivery and skin wound healing | |
| Morgan et al. | Tissue-factor targeted peptide amphiphile nanofibers as an injectable therapy to control hemorrhage | |
| Han et al. | A supramolecular hydrogel based on the combination of YIGSR and RGD enhances mesenchymal stem cells paracrine function via integrin α2β1 and PI3K/AKT signaling pathway for acute kidney injury therapy | |
| EP2568995B1 (en) | Therapeutic use of agonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth | |
| Li et al. | Adaptive enzyme-responsive self-assembling multivalent apelin ligands for targeted myocardial infarction therapy | |
| WO2021187478A1 (en) | Composition containing self-assembling peptide | |
| CA2592292A1 (en) | Sustained delivery of pdgf using self-assembling peptide nanofibers | |
| KR20170016857A (en) | Selectin and icam/vcam peptide ligand conjugates | |
| Xie et al. | Retro-inverso bradykinin opens the door of blood–brain tumor barrier for nanocarriers in glioma treatment | |
| Choi et al. | Injectable PLGA microspheres encapsulating WKYMVM peptide for neovascularization | |
| Ruan et al. | Stapled RAP12 peptide ligand of LRP1 for micelles-based multifunctional glioma-targeted drug delivery | |
| JP2022544481A (en) | Applications of polypeptides or derivatives thereof | |
| CN110229215A (en) | A kind of medicament slow release polypeptide hydrogel and its preparation method and application | |
| Zhen et al. | ROS-differentiated release of Apelin-13 from hydrogel comprehensively treats myocardial ischemia-reperfusion injury | |
| JP7805589B2 (en) | Self-assembling peptides | |
| Wei et al. | Supramolecular self-assembling IGF-1 nanofibers modulate neutrophil extracellular traps to accelerate diabetic wound healing | |
| CN109453364B (en) | A Dual Responsive Nanoparticle and Its Application in Tumor Suppression | |
| US9169294B2 (en) | Anti-angiogenic molecules, nanostructures and uses thereof | |
| Zhang et al. | Natural bioactive lysosomes extracted from multiple cells for tumor therapy | |
| EP2108698A1 (en) | Vascular endothelial cell-binding peptide | |
| Bian et al. | Enzyme-instructed self-assembled supramolecular bi-antibodies for inhibition and imaging of atherosclerosis progression | |
| Wang et al. | QKCMP peptide carrier macromolecule structure and release system based on triangular DNA origami nanostructures: A novel strategy for promoting angiogenesis | |
| Xing et al. | Click method preserves but EDC method compromises the therapeutic activities of the peptide-activated hydrogels for critical ischemic vessel regeneration |